Secondary sclerosing cholangitis after critical COVID-19:Three case reports

作     者：Juan M Mayorquín-Aguilar Aldo Lara-Reyes Luis Alberto Revuelta-Rodríguez Nayelli C Flores-García Astrid Ruiz-Margáin Marco Antonio Jiménez-Ferreira Ricardo Ulises Macías-Rodríguez 

作者机构：Department of GastroenterologyInstituto Nacional de Ciencias Médicas y Nutrición Salvador ZubiránMexico City 14080Mexico Department of PathologyInstituto Nacional de Ciencias Médicas y Nutrición Salvador ZubiránMexico City 14080Mexico 

出 版 物：《World Journal of Hepatology》 (世界肝病学杂志（英文版）（电子版）)

年 卷 期：2022年第14卷第8期

页      面：1678-1686页

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

主　　题：SARS-CoV-2 Persistent cholestasis Liver chemistry Hypoxic cholangiopathy Case report 

摘      要：BACKGROUND The global coronavirus disease 2019(COVID-19)pandemic has caused more than 5 million *** involvement is well described,including liver *** patients with critical COVID-19,a new entity calledpost-COVID-19 cholangiopathyhas been *** SUMMARY Here,we present three patients with severe COVID-19 that subsequently developed persistent cholestasis and chronic liver *** three patients required intensive care unit admission,mechanical ventilation,vasopressor support,and broad spectrum antibiotics due to secondary *** transplant protocol was started for two of the three *** Severe COVID-19 infection should be considered a potential risk factor for chronic liver disease and liver transplantation.